hexamethonium has been researched along with Blood Pressure, High in 275 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Excerpt | Relevance | Reference |
---|---|---|
"This study aimed to evaluate whether exercise training could contribute to a better modulation of the neurohumoral mechanisms linked to the pathophysiology of arterial hypertension (AH) in postmenopausal hypertensive rats treated with hydrochlorothiazide (HCTZ)." | 8.31 | Concurrent exercise training induces additional benefits to hydrochlorothiazide: Evidence for an improvement of autonomic control and oxidative stress in a model of hypertension and postmenopause. ( Bernardes, N; da Silva Dias, D; De Angelis, K; Ferreira, MJ; Irigoyen, MC; Santos Ferreira Silva, MPD, 2023) |
"Many studies have implicated both angiotensin II (ANG II) and aldosterone (Aldo) in the pathogenesis of hypertension, the progression of renal injury, and cardiac remodeling after myocardial infarction." | 7.77 | Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. ( Beltz, TG; Gomez-Sanchez, CE; Guo, F; Hay, M; Johnson, AK; Xue, B; Yu, Y, 2011) |
"This study was conducted to examine if central amiloride-sensitive transport systems are involved in the development and/or maintenance of hypertension in spontaneously hypertensive rats (SHR)." | 7.71 | Contribution of central amiloride-sensitive transport systems to the development of hypertension in spontaneously hypertensive rats. ( Akahoshi, M; Kitamura, S; Nagao, S; Nonaka, M; Seto, S; Yano, K, 2001) |
"To explore the pathophysiological role of leptin in obesity-related hypertension, we examined cardiovascular phenotypes of transgenic skinny mice whose elevated plasma leptin concentrations are comparable to those seen in obese subjects." | 7.70 | Pathophysiological role of leptin in obesity-related hypertension. ( Aizawa-Abe, M; Ebihara, K; Hayashi, T; Hosoda, K; Inoue, G; Iwai, H; Masuzaki, H; Matsuoka, N; Nakao, K; Ogawa, Y; Satoh, N; Yoshimasa, Y, 2000) |
"The purpose of the present study was to identify mechanisms that contribute to increased venous smooth muscle tone in desoxycorticosterone acetate (DOCA)-salt hypertension in rats." | 7.70 | Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. ( Fink, GD; Galligan, JJ; Johnson, RJ, 2000) |
" To investigate the mechanisms by which bupivacaine may act within the CNS to produce cardiovascular toxicity, we studied four groups of halothane-anesthetized rabbits in which infusion of intracerebroventricular (icv) bupivacaine or intravenous (iv) phenylephrine resulted in dysrhythmias and hypertension." | 7.68 | Hexamethonium and midazolam terminate dysrhythmias and hypertension caused by intracerebroventricular bupivacaine in rabbits. ( Artu, AA; Bernards, CM, 1991) |
"The objective of this study was to determine if ablation of the lateral parabrachial nucleus (LPBN) would prevent angiotensin II-induced hypertension in rats." | 7.68 | Lateral parabrachial nucleus and angiotensin II-induced hypertension. ( Fink, GD; Haywood, JR; Ohman, LE; Pawloski, CM, 1991) |
"Twenty-one patients have been treated for hypertension with oral doses of hexamethonium salts, Apresoline(R) or combinations of both." | 7.63 | Hexamethonium and hydralazine hydrochloride for treatment of hypertension. ( STUPPY, LJ, 1954) |
"When hexamethonium was used to assess autonomic control of MAP, no differences in the decrease of MAP in response to ganglionic blockade were detected during the induction." | 5.40 | CNS neuroplasticity and salt-sensitive hypertension induced by prior treatment with subpressor doses of ANG II or aldosterone. ( Beltz, T; Clayton, SC; Johnson, AK; Xue, B; Zhang, Z, 2014) |
"Nicotine (200 mg/kg) was administered as a single bolus, as infusions lasting 7." | 5.30 | Tachyphylaxis and sensitization to nicotine-induced tachycardiac and pressor effects after nicotine infusions. ( Cruz, SL; Vidrio, H, 1997) |
"Pretreatment with prazosin (0." | 5.28 | Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area. ( Bouysset, F; Laubie, M; Schmitt, H; Vayssettes-Courchay, C; Verbeuren, TJ, 1991) |
"Hexamethonium is a potent anti-hypertensive agent." | 5.23 | Use of hexamethonium in arterial hypertension. ( RYTAND, DA, 1954) |
" Some of this information includes: the unexpected yet very real hazards as well as benefits associated with the long-term use of powerful drugs, in particular the original description of hydralazine-induced lupus, its relation to genetic markers and its association with control of hypertension; the apparently decreasing need for antihypertensive drugs in subjects with well-controlled severe and moderate hypertension; the identification of risk factors for the complications of hypertension and the quantitation of their effects; the decrease in the incidence of hypertensive complications associated with the pharmacologic treatment of severe, moderate and, at least, the upper ranges of mild hypertension; the possibility of designing a chemical to block a specific reaction and the realization that it would have broader than expected effects; and the primary prevention of myocardial infarction in very high risk subjects." | 4.77 | The evolution of antihypertensive therapy. ( Perry, HM, 1985) |
"This study aimed to evaluate whether exercise training could contribute to a better modulation of the neurohumoral mechanisms linked to the pathophysiology of arterial hypertension (AH) in postmenopausal hypertensive rats treated with hydrochlorothiazide (HCTZ)." | 4.31 | Concurrent exercise training induces additional benefits to hydrochlorothiazide: Evidence for an improvement of autonomic control and oxidative stress in a model of hypertension and postmenopause. ( Bernardes, N; da Silva Dias, D; De Angelis, K; Ferreira, MJ; Irigoyen, MC; Santos Ferreira Silva, MPD, 2023) |
"Lead is considered a causative factor for hypertension and other cardiovascular diseases." | 3.85 | Sub-chronic lead exposure produces β ( Alonso, MJ; Fioresi, M; Salaices, M; Simões, MR; Toscano, CM; Vassallo, DV, 2017) |
"Early hexamethonium treatment attenuates acute excessive release of catecholamines to prevent cardiac dysfunction and pulmonary edema for increasing survival rate." | 3.79 | Hexamethonium reverses the lethal cardiopulmonary damages in a rat model of brainstem lesions mimicking fatal enterovirus 71 encephalitis. ( Ger, LP; Ho, WY; Hsiao, M; Hsieh, KS; Lai, CC; Lu, PJ; Lu, WH; Tseng, CJ; Wang, JS; Wu, YS, 2013) |
"Many studies have implicated both angiotensin II (ANG II) and aldosterone (Aldo) in the pathogenesis of hypertension, the progression of renal injury, and cardiac remodeling after myocardial infarction." | 3.77 | Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. ( Beltz, TG; Gomez-Sanchez, CE; Guo, F; Hay, M; Johnson, AK; Xue, B; Yu, Y, 2011) |
"This study was conducted to examine if central amiloride-sensitive transport systems are involved in the development and/or maintenance of hypertension in spontaneously hypertensive rats (SHR)." | 3.71 | Contribution of central amiloride-sensitive transport systems to the development of hypertension in spontaneously hypertensive rats. ( Akahoshi, M; Kitamura, S; Nagao, S; Nonaka, M; Seto, S; Yano, K, 2001) |
"Because the ET(B) receptor is important in venoconstriction, we examined the effects of a selective ET(B) receptor antagonist (A-1 92621) and a mixed ET(A/B) receptor antagonist (A-182086) on endogenous endothelin-1 (ET-1) contributions to elevated venomotor tone in deoxycorticosterone acetate-salt (DOCA-salt) hypertension." | 3.71 | Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension. ( Fink, GD; Galligan, JJ; Johnson, RJ, 2001) |
"To explore the pathophysiological role of leptin in obesity-related hypertension, we examined cardiovascular phenotypes of transgenic skinny mice whose elevated plasma leptin concentrations are comparable to those seen in obese subjects." | 3.70 | Pathophysiological role of leptin in obesity-related hypertension. ( Aizawa-Abe, M; Ebihara, K; Hayashi, T; Hosoda, K; Inoue, G; Iwai, H; Masuzaki, H; Matsuoka, N; Nakao, K; Ogawa, Y; Satoh, N; Yoshimasa, Y, 2000) |
"The purpose of the present study was to identify mechanisms that contribute to increased venous smooth muscle tone in desoxycorticosterone acetate (DOCA)-salt hypertension in rats." | 3.70 | Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. ( Fink, GD; Galligan, JJ; Johnson, RJ, 2000) |
"After saline pretreatment, response to 5-HT consisted of immediate and brief apnea, bradycardia, and hypotension, followed by sustained tachypnea, tachycardia, pulmonary hypertension, and hypocapnic hypoxemia." | 3.69 | Parasympathetic component of 5-hydroxytryptamine-induced pulmonary dysfunctions in healthy calves. ( Amory, H; Desmecht, DJ; Lekeux, PM; Linden, AS, 1996) |
"We examined the effect of pioglitazone, a thiazolidinedione derivative that increases insulin sensitivity without increasing insulin secretion, on the development and maintenance of hypertension in sucrose-fed SHR." | 3.69 | Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR. ( Fujita, H; Hatta, T; Itoh, H; Kawa, T; Kiyama, M; Miki, S; Moriguchi, J; Morimoto, S; Nakagawa, M; Nakamura, K; Nakata, T; Sasaki, S; Takeda, K; Uchida, A, 1997) |
" To investigate the mechanisms by which bupivacaine may act within the CNS to produce cardiovascular toxicity, we studied four groups of halothane-anesthetized rabbits in which infusion of intracerebroventricular (icv) bupivacaine or intravenous (iv) phenylephrine resulted in dysrhythmias and hypertension." | 3.68 | Hexamethonium and midazolam terminate dysrhythmias and hypertension caused by intracerebroventricular bupivacaine in rabbits. ( Artu, AA; Bernards, CM, 1991) |
"The objective of this study was to determine if ablation of the lateral parabrachial nucleus (LPBN) would prevent angiotensin II-induced hypertension in rats." | 3.68 | Lateral parabrachial nucleus and angiotensin II-induced hypertension. ( Fink, GD; Haywood, JR; Ohman, LE; Pawloski, CM, 1991) |
"To elucidate the role of the dopaminergic system in the maintenance of hypertension in the deoxycorticosterone acetate (DOCA)/NaCl hypertensive rat, the responses of mean arterial pressure (MAP), plasma norepinephrine (NE), epinephrine (E), and prolactin (PRL) to intravenous (iv) administration of bromocriptine, a dopamine agonist, and hexamethonium bromide, a ganglion blocker, were examined in conscious, unrestrained 4-wk DOCA/NaCl hypertensive rats." | 3.67 | Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat. ( Chen, YF; Nagahama, S; Oparil, S, 1985) |
"A central pressor effect of angiotensin II (ANG II) has been implicated in the pathogenesis of several forms of experimental hypertension." | 3.67 | Neurohumoral contributions to chronic angiotensin-induced hypertension. ( Bruner, CA; Fink, GD, 1986) |
"Twenty-one patients have been treated for hypertension with oral doses of hexamethonium salts, Apresoline(R) or combinations of both." | 3.63 | Hexamethonium and hydralazine hydrochloride for treatment of hypertension. ( STUPPY, LJ, 1954) |
"When hexamethonium was used to assess autonomic control of MAP, no differences in the decrease of MAP in response to ganglionic blockade were detected during the induction." | 1.40 | CNS neuroplasticity and salt-sensitive hypertension induced by prior treatment with subpressor doses of ANG II or aldosterone. ( Beltz, T; Clayton, SC; Johnson, AK; Xue, B; Zhang, Z, 2014) |
"Obesity is one of the major risk factors for cardiovascular disease and is often associated with increased oxidative stress and sympathoexcitation." | 1.35 | Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. ( Ando, K; Fujita, M; Fujita, T; Kawarazaki, H; Matsui, H; Nagae, A, 2009) |
"Losartan-treated (LOS group, n = 10) and untreated rats served as controls (n = 11)." | 1.35 | Hyperinsulinemic rats are normotensive but sensitized to angiotensin II. ( Alexanderson, C; Andersson, IJ; Bergström, G; Holmäng, A; Johansson, ME; Skøtt, O, 2008) |
"Hypertension was induced in male Sprague-Dawley rats (n=40) by suprarenal aortic coarctation." | 1.30 | Food restriction attenuates the blood pressure response to paraventricular hypothalamic nuclei lesions in aortic coarctation hypertension. ( Casto, RM; DeMaria, JE; Overton, JM; VanNess, JM, 1998) |
"Nicotine (200 mg/kg) was administered as a single bolus, as infusions lasting 7." | 1.30 | Tachyphylaxis and sensitization to nicotine-induced tachycardiac and pressor effects after nicotine infusions. ( Cruz, SL; Vidrio, H, 1997) |
" At 16 weeks of age more-complete dose-response curves to the alpha 1-agonist methoxamine were also constructed." | 1.29 | Arterial hypertrophy and pressor responsiveness during development of hypertension in spontaneously hypertensive rats. ( Lee, RM; Leenen, FH; Tsoporis, J; Yuan, B, 1994) |
"Pretreatment with hexamethonium prevented neither acute nor more enduring behavioral deficits observed after TBI." | 1.28 | Blockade of acute hypertensive response does not prevent changes in behavior or in CSF acetylcholine (ACH) content following traumatic brain injury (TBI). ( Enters, EK; Kapasi, MZ; McDowell, KP; Pascua, JR; Povlishock, JT; Robinson, SE, 1992) |
"Pretreatment with prazosin (0." | 1.28 | Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area. ( Bouysset, F; Laubie, M; Schmitt, H; Vayssettes-Courchay, C; Verbeuren, TJ, 1991) |
"Hexamethonium is a potent anti-hypertensive agent." | 1.23 | Use of hexamethonium in arterial hypertension. ( RYTAND, DA, 1954) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 196 (71.27) | 18.7374 |
1990's | 33 (12.00) | 18.2507 |
2000's | 32 (11.64) | 29.6817 |
2010's | 12 (4.36) | 24.3611 |
2020's | 2 (0.73) | 2.80 |
Authors | Studies |
---|---|
Braga, DCA | 1 |
Gomes, PM | 2 |
Batista, MAC | 1 |
de Souza, JA | 1 |
Bastos, JCSA | 1 |
Rodrigues-das-Dôres, RG | 1 |
Alzamora, AC | 2 |
de Souza, GHB | 1 |
de Moura, SAL | 1 |
Talvani, A | 1 |
Antunes, VR | 2 |
Cardoso, LM | 2 |
Ferreira, MJ | 1 |
Santos Ferreira Silva, MPD | 1 |
da Silva Dias, D | 1 |
Bernardes, N | 1 |
Irigoyen, MC | 1 |
De Angelis, K | 2 |
Toscano, CM | 1 |
Simões, MR | 1 |
Alonso, MJ | 1 |
Salaices, M | 1 |
Vassallo, DV | 2 |
Fioresi, M | 1 |
Sá, RWM | 1 |
Aguiar, GL | 1 |
Paes, MHS | 1 |
Lima, WG | 1 |
de Oliveira, LB | 1 |
Stocker, SD | 1 |
Guild, SJ | 1 |
Saxena, UA | 1 |
McBryde, FD | 1 |
Malpas, SC | 1 |
Ramchandra, R | 1 |
Nyquist, P | 1 |
Wang, Y | 1 |
Chen, L | 1 |
Wier, WG | 1 |
Zhang, J | 1 |
Clayton, SC | 1 |
Zhang, Z | 1 |
Beltz, T | 1 |
Xue, B | 5 |
Johnson, AK | 5 |
Koga, Y | 1 |
Hirooka, Y | 2 |
Araki, S | 1 |
Nozoe, M | 1 |
Kishi, T | 1 |
Sunagawa, K | 1 |
Nagae, A | 1 |
Fujita, M | 1 |
Kawarazaki, H | 1 |
Matsui, H | 1 |
Ando, K | 3 |
Fujita, T | 3 |
Badaue-Passos, D | 1 |
Guo, F | 3 |
Gomez-Sanchez, CE | 2 |
Hay, M | 4 |
Moreira, TS | 1 |
Takakura, AC | 1 |
Colombari, E | 2 |
Menani, JV | 2 |
Moritz, KM | 1 |
Dodic, M | 1 |
Jefferies, AJ | 1 |
Wintour, EM | 1 |
DeMatteo, R | 1 |
Singh, RR | 1 |
Evans, RG | 1 |
Singh, M | 1 |
Beltz, TG | 2 |
Yu, Y | 1 |
Zhao, G | 1 |
Walsh, E | 1 |
Shryock, JC | 1 |
Messina, E | 1 |
Wu, Y | 1 |
Zeng, D | 1 |
Xu, X | 1 |
Ochoa, M | 1 |
Baker, SP | 1 |
Hintze, TH | 1 |
Belardinelli, L | 1 |
Kuroki, MT | 1 |
Guzman, PA | 1 |
Fink, GD | 6 |
Osborn, JW | 3 |
Nishida, Y | 1 |
Tandai-Hiruma, M | 1 |
Kemuriyama, T | 1 |
Hagisawa, K | 1 |
Leal, AK | 2 |
Murphy, MN | 1 |
Iwamoto, GA | 1 |
Mitchell, JH | 2 |
Smith, SA | 2 |
Lu, WH | 1 |
Hsieh, KS | 1 |
Lu, PJ | 1 |
Wu, YS | 1 |
Ho, WY | 1 |
Lai, CC | 1 |
Wang, JS | 1 |
Ger, LP | 1 |
Hsiao, M | 1 |
Tseng, CJ | 1 |
Sato, MA | 1 |
Schoorlemmer, GH | 1 |
Lopes, OU | 1 |
CAMERON, AJ | 1 |
BURN, RA | 1 |
MILLS, LC | 4 |
MOYER, JH | 13 |
SMIRK, FH | 7 |
LANE, R | 1 |
MCQUEEN, EG | 1 |
PALMER, AJ | 1 |
KVALE, WF | 1 |
MCCALLA, LH | 1 |
CREECH, O | 1 |
FORD, RV | 7 |
KELLEY, RT | 1 |
FREIS, ED | 5 |
HIGGINS, TF | 1 |
SHAW, GB | 2 |
PAGE, IH | 2 |
PAGE, I | 1 |
TAYLOR, RD | 1 |
CORCORAN, AC | 1 |
LIAN, C | 1 |
SNYDER, BH | 1 |
JOHNSON, I | 2 |
MILLER, SI | 5 |
CARRAL, R | 1 |
TRANCHESI, J | 1 |
SOTO ROJAS, G | 1 |
HERRMANN, GR | 1 |
CONWAY, J | 2 |
RICH, CB | 1 |
HOLUBITSKY, WH | 1 |
ROEHM, DC | 1 |
KORY, RC | 1 |
MENEELY, GR | 1 |
MORRISON, B | 3 |
SHAPERA, RP | 1 |
LANG, FR | 1 |
ROMNEY, RB | 1 |
BULLINGTON, RH | 1 |
ABILDSKOV, JA | 1 |
RAY, CT | 1 |
BURCH, GE | 1 |
KLAYMAN, MI | 1 |
SILBERG, NR | 1 |
KARLEN, WS | 1 |
KUHN, PH | 1 |
HIRSHLEIFER, I | 1 |
SCHWARTZ, G | 1 |
FISHMAN, SI | 1 |
FANKHAUSER, AM | 1 |
HAUGEN, HN | 1 |
BLEGEN, EM | 1 |
SHAPIRO, AP | 1 |
GROLLMAN, A | 1 |
GROB, D | 2 |
LANGFORD, HG | 2 |
HILKER, RR | 1 |
RHOADS, PS | 1 |
BILLINGS, CE | 1 |
LIVESAY, WR | 1 |
SNYDER, HB | 1 |
Rønnov-Jessen, V | 5 |
Bech, V | 1 |
SCARBOROUGH, WR | 1 |
KATTUS, AA | 1 |
BRUNNER, D | 3 |
RAFSKY, HA | 1 |
HORONICK, A | 1 |
RAFSKY, JC | 1 |
RONNOV-JESSEN, V | 1 |
DEWAR, HA | 2 |
OWEN, SG | 1 |
JENKINS, AR | 1 |
CUBBERLY, RB | 1 |
WIESEL, LL | 1 |
LAMB, AE | 1 |
MURPHY, EA | 2 |
EASTWOOD, J | 1 |
STEEVES, LC | 1 |
SHEARS, AH | 1 |
SPELLER, SL | 1 |
McCUBBIN, JW | 1 |
SIEBER, HA | 3 |
GRIMSON, KS | 1 |
ORGAIN, ES | 3 |
SPURR, CL | 2 |
DUPUY, HJ | 1 |
SIGNORELLI, JJ | 1 |
HULL, E | 1 |
GALEN, WP | 2 |
JOHNSON, LL | 1 |
WILSON, AG | 1 |
HARINGTON, M | 1 |
ROSENHEIM, ML | 1 |
FRANCO, A | 1 |
CRUMPTON, CW | 2 |
ROWE, GG | 2 |
O'BRIEN, G | 1 |
MURPHY, QR | 2 |
DONIACH, I | 1 |
STEINER, RE | 2 |
STUPPY, LJ | 1 |
PERRETTA, A | 2 |
GUIDO, JJ | 1 |
WILSON, VH | 1 |
KEELEY, KJ | 1 |
HOOD, B | 1 |
BJORK, S | 1 |
ANGERVALL, G | 1 |
RUDBACK, H | 1 |
RYTAND, DA | 1 |
GREEN, DM | 1 |
ELLIS, EJ | 1 |
EURMAN, GH | 1 |
MENDLOWITZ, M | 1 |
CAPRETTI, G | 1 |
MAGNANI, B | 2 |
FALZOI, M | 1 |
GELATI, M | 1 |
GUNELLA, G | 1 |
SCHIMMLER, W | 1 |
SCHWALB, H | 1 |
CESARMAN, T | 1 |
TORRES DEL TORO, JM | 1 |
BARNETT, AJ | 1 |
FRASER, JR | 1 |
HAMILTON, M | 1 |
HENLEY, KS | 1 |
MANDELBAUM, H | 1 |
BROOK, J | 1 |
MANDELBAUM, RA | 1 |
ROSSI, B | 1 |
FERRARA, FA | 1 |
LEMAIRE, A | 1 |
LOEPER, J | 1 |
HOUSSET, E | 1 |
FRANCO, R | 1 |
ESCALADA, JG | 1 |
ALONSO JIMENO, S | 1 |
GONZALEZ MARTINEZ, A | 1 |
CRAWLEY, CJ | 2 |
SILVIS, GM | 2 |
STUMPE, WM | 2 |
WHITE, L | 1 |
THOMSEN, P | 1 |
ORTUZAR, R | 1 |
GONI, F | 1 |
ROJAS VILLEGAS, F | 1 |
SILVA LAFRENTZ, C | 1 |
TOLEDO, P | 1 |
SILVA CLARK, A | 1 |
VERA, G | 1 |
CHIAVERINI, R | 1 |
DA SILVA, WN | 1 |
DUKE, JE | 1 |
KLEH, J | 1 |
FAZEKAS, JF | 1 |
GUIDO, JG | 1 |
NAVARRET, E | 1 |
DENNIS, E | 3 |
McCONN, RG | 1 |
HUGHES, WM | 2 |
BEAZLEY, HL | 1 |
BIRKHEAD, NC | 1 |
ALLEN, EV | 1 |
RAST, CL | 2 |
SMITH, KS | 1 |
FOWLER, PB | 1 |
EDMUNDS, V | 1 |
HRENOFF, AK | 1 |
LOVISATO, L | 1 |
ROQUE, JA | 1 |
GENEST, J | 3 |
ROBILLARD, R | 3 |
TREMBLAY, G | 3 |
ADAMKIEWICZ, L | 3 |
CAPPS, RC | 1 |
WHITMORE, JJ | 1 |
BURCH, RR | 1 |
DE SIMONE, G | 1 |
MASELLIS, F | 1 |
GOLDSMITH, HJ | 1 |
BEAVEN, DW | 1 |
LAMBERT, HP | 1 |
TARJAN, P | 1 |
CSIPAK, Z | 1 |
BARATH, J | 1 |
BRUCE, GM | 1 |
MULLER, JC | 1 |
PRYOR, WW | 1 |
PIPBERGER, H | 1 |
KALIN, R | 1 |
ROSSIER, PH | 1 |
MCCLOSKEY, BJ | 1 |
FORD, R | 1 |
HERSCHBERGER, R | 1 |
SPENCE, W | 1 |
HERSHBERGER, RL | 1 |
BONA, E | 1 |
LOVEI, E | 1 |
PERALTA, A | 1 |
CASTANEDA, L | 1 |
ARREDONDO, J | 1 |
PEREZ, V | 1 |
CAMACHO, J | 1 |
ESTELA, M | 1 |
AUINGER, W | 1 |
HEROLD, G | 1 |
SALAND, G | 1 |
FISCHER, I | 1 |
HERNRIED, HP | 1 |
STOLIAR, ED | 1 |
ZURROW, HB | 1 |
ULLMANN, TD | 1 |
MENCZEL, J | 1 |
BARTORELLI, C | 1 |
GOLDBERG, B | 2 |
DALLE COSTE, P | 1 |
KLINGER, R | 1 |
ETTMAN, IK | 1 |
BOUCHILLON, CD | 1 |
HALFORD, HH | 1 |
BALCHUM, OJ | 1 |
GENSINI, G | 1 |
BLOUNT, SG | 1 |
LINDAUER, MA | 1 |
HAFKENSCHIEL, JH | 1 |
RESTREPO, G | 1 |
BAUER, H | 1 |
ERLSBACHER, O | 1 |
GEISBERGER, H | 1 |
MEDA, A | 1 |
DUGHERA, L | 1 |
PETERSEN, AG | 1 |
DODGE, M | 1 |
HELWIG, FC | 1 |
HAYNES, FW | 1 |
DEXTER, L | 1 |
VARELA DE SEIJAS AGUILAR, J | 1 |
FERNANDEZ ARENAS, M | 1 |
ESQUIVEL JIMENEZ, A | 1 |
MARCHAN COLADO, A | 1 |
DIAZ, JM | 1 |
KALUGINA, GV | 1 |
MOSCHINI-ANTINORI, E | 1 |
MENOTTI, A | 1 |
SPLENDIANI, G | 1 |
BARDIN, EV | 1 |
AKHREM-AKHREMOVICH, RM | 1 |
CHISTIAKOVA, MA | 1 |
KONONIACHENKO, VA | 1 |
CHAPIDZE, GE | 1 |
HAZARD, R | 1 |
RENIER CORNEC, A | 1 |
IVANOV, IuM | 1 |
BANTOVA, TG | 1 |
SANCETTA, SM | 1 |
RIOPELLE, JL | 1 |
MARKOVITZ, M | 1 |
KOIK, JV | 1 |
HICK, FK | 1 |
GRISSOM, RL | 1 |
GRIGOLATO, V | 1 |
ALLAN, J | 1 |
STEIN, DH | 1 |
HECHT, HH | 1 |
FERRARI, S | 1 |
MOSER, M | 1 |
ALTMAN, S | 1 |
SCHINDEL, L | 1 |
HIMBERT, J | 1 |
GRAS, H | 1 |
PHELAN, EL | 1 |
ERYETISHIR, I | 1 |
Toscano, CF | 1 |
Lahlou, S | 1 |
CAMPBELL, A | 1 |
ROBERTSON, E | 1 |
McNALLY, PA | 1 |
CUSACK, PB | 1 |
CUSACK, AL | 1 |
ALSTAD, KS | 1 |
MACKEY, WA | 1 |
COUNIHAN, T | 1 |
WERKO, L | 1 |
WADE, G | 1 |
FRISK, AR | 1 |
ELLASCH, H | 1 |
BECHGAARD, P | 1 |
IVERSEN, T | 1 |
NIELSEN, AL | 1 |
LOCKET, S | 1 |
SWANN, PG | 1 |
GRIEVE, WS | 1 |
PLAYER, HP | 1 |
FINNERTY, FA | 1 |
SCHNAPER, NW | 1 |
JOHNSON, RL | 2 |
PERSSON, I | 1 |
SCHROEDER, HA | 1 |
CHAPMAN, OW | 1 |
SCHNAPER, HW | 1 |
FREEMAN, Z | 1 |
KOK, JF | 1 |
DI CIO, AV | 1 |
KLEIN, L | 1 |
LOPEZ, A | 1 |
PAZZANESE, D | 1 |
DE BARROS, LM | 1 |
DE CAMARGO, FS | 1 |
BURT, CC | 1 |
GRAHAM, AJ | 1 |
RESTALL, PA | 1 |
Hendel, MD | 1 |
Collister, JP | 2 |
Pamidimukkala, J | 1 |
Seto, S | 2 |
Nagao, S | 2 |
Ozeki, S | 1 |
Tetsuo, H | 1 |
Akahoshi, M | 2 |
Yano, K | 2 |
O'Donaughy, TL | 1 |
Qi, Y | 1 |
Brooks, VL | 1 |
Williams, MA | 1 |
Garry, MG | 1 |
Zoccal, DB | 1 |
Bonagamba, LG | 1 |
Oliveira, FR | 1 |
Antunes-Rodrigues, J | 1 |
Machado, BH | 1 |
Freitas, RR | 1 |
Lopes, KL | 1 |
Carillo, BA | 1 |
Bergamaschi, CT | 1 |
Carmona, AK | 1 |
Casarini, DE | 1 |
Furukawa, L | 1 |
Heimann, JC | 1 |
Campos, RR | 1 |
Dolnikoff, MS | 1 |
Maeda, C | 1 |
Schaan, B | 1 |
Oliveira, E | 1 |
Oliveira, V | 1 |
Irigoyen, M | 1 |
Chen, X | 1 |
Patel, K | 1 |
Connors, SG | 1 |
Mendonca, M | 1 |
Welch, WJ | 2 |
Wilcox, CS | 2 |
Guzman, P | 1 |
Johansson, ME | 1 |
Andersson, IJ | 1 |
Alexanderson, C | 1 |
Skøtt, O | 1 |
Holmäng, A | 1 |
Bergström, G | 1 |
Lizardo, JH | 1 |
Silveira, EA | 1 |
Oliveira, EM | 1 |
Maixner, W | 1 |
Touw, KB | 1 |
Brody, MJ | 1 |
Gebhart, GF | 1 |
Long, JP | 1 |
Brennan, TJ | 1 |
Haywood, JR | 2 |
Ticku, MK | 1 |
Panikarskiĭ, VG | 1 |
Barnes, KL | 1 |
Averill, DB | 1 |
Ferrario, CM | 1 |
Sorrentino, R | 1 |
Pinto, A | 1 |
Santajuliana, D | 1 |
Zukowska-Grojec, Z | 1 |
Toda, N | 1 |
Kitamura, Y | 1 |
Okamura, T | 1 |
Nakagawa, M | 3 |
Takeda, K | 3 |
Yoshitomi, T | 1 |
Itoh, H | 2 |
Nakata, T | 3 |
Sasaki, S | 3 |
Leenen, FH | 5 |
Yuan, B | 2 |
Tsoporis, J | 1 |
Lee, RM | 1 |
Ono, A | 1 |
Sato, Y | 2 |
Asano, S | 1 |
Amano, M | 1 |
Asari, T | 1 |
Kubo, T | 1 |
Yang, TL | 1 |
Yen, CT | 2 |
Chai, CY | 2 |
Wyss, JM | 3 |
Mozaffari, MS | 2 |
Roysommuti, S | 2 |
Linden, AS | 1 |
Desmecht, DJ | 1 |
Amory, H | 1 |
Lekeux, PM | 1 |
Momohara, M | 1 |
Imaizumi, T | 1 |
Endo, T | 1 |
Suzuki, S | 1 |
Tagawa, T | 1 |
Shiramoto, M | 1 |
Masaki, H | 1 |
Takeshita, A | 2 |
Cruz, SL | 1 |
Vidrio, H | 1 |
Oosting, J | 1 |
Struijker-Boudier, HA | 1 |
Janssen, BJ | 2 |
Uchida, A | 1 |
Hatta, T | 1 |
Kiyama, M | 1 |
Kawa, T | 1 |
Morimoto, S | 1 |
Miki, S | 1 |
Moriguchi, J | 1 |
Nakamura, K | 1 |
Fujita, H | 1 |
Gao, H | 1 |
DiBona, GF | 1 |
VanNess, JM | 1 |
Casto, RM | 1 |
DeMaria, JE | 1 |
Overton, JM | 1 |
Radaelli, A | 1 |
Mircoli, L | 1 |
Mori, I | 1 |
Mancia, G | 1 |
Ferrari, AU | 1 |
Han, CJ | 1 |
Tsai, ML | 1 |
Chen, RF | 1 |
Davisson, RL | 1 |
Yang, G | 1 |
Cassell, MD | 1 |
Sigmund, CD | 1 |
Chen, Y | 1 |
Collins, HL | 1 |
DiCarlo, SE | 1 |
Nagayama, T | 1 |
Matsumoto, T | 1 |
Yoshida, M | 1 |
Suzuki-Kusaba, M | 1 |
Hisa, H | 1 |
Kimura, T | 1 |
Satoh, S | 1 |
Amos, S | 1 |
Akah, PA | 1 |
Odukwe, CJ | 1 |
Gamaniel, KS | 1 |
Wambede, C | 1 |
Carlson, SH | 1 |
Shelton, J | 1 |
White, CR | 1 |
Johnson, RJ | 2 |
Galligan, JJ | 2 |
Greyson, C | 1 |
Xu, Y | 1 |
Lu, L | 1 |
Schwartz, GG | 1 |
Aizawa-Abe, M | 1 |
Ogawa, Y | 1 |
Masuzaki, H | 1 |
Ebihara, K | 1 |
Satoh, N | 1 |
Iwai, H | 1 |
Matsuoka, N | 1 |
Hayashi, T | 1 |
Hosoda, K | 1 |
Inoue, G | 1 |
Yoshimasa, Y | 1 |
Nakao, K | 1 |
Eshima, K | 1 |
Shigematsu, H | 1 |
Matsuo, I | 1 |
Koike, G | 1 |
Sakai, K | 1 |
Iriuchijima, J | 2 |
Rong, P | 1 |
Wilkinson-Berka, JL | 1 |
Skinner, SL | 1 |
Kitamura, S | 1 |
Nonaka, M | 1 |
Teranishi, Y | 1 |
Sugino, H | 1 |
Ozono, R | 1 |
Ishioka, N | 1 |
Kumazaki, T | 1 |
Tsuru, H | 1 |
Ueno, K | 1 |
Togashi, H | 1 |
Matsumoto, M | 1 |
Ohashi, S | 1 |
Saito, H | 1 |
Yoshioka, M | 1 |
Boura, AL | 1 |
Abdel-Rahman, AA | 1 |
Carroll, RG | 1 |
el-Mas, MM | 1 |
Enters, EK | 1 |
Pascua, JR | 1 |
McDowell, KP | 1 |
Kapasi, MZ | 1 |
Povlishock, JT | 1 |
Robinson, SE | 1 |
Bernards, CM | 1 |
Artu, AA | 1 |
Pawloski, CM | 2 |
Ohman, LE | 1 |
Vayssettes-Courchay, C | 1 |
Bouysset, F | 1 |
Verbeuren, TJ | 1 |
Laubie, M | 1 |
Schmitt, H | 1 |
Stoos, BA | 1 |
Metting, PJ | 1 |
Britton, SL | 1 |
Takata, Y | 2 |
Yamashita, Y | 2 |
Takishita, S | 2 |
Tomita, Y | 1 |
Tsuchihashi, T | 1 |
Nakao, Y | 1 |
Iwase, M | 1 |
Sadoshima, S | 1 |
Fujishima, M | 2 |
van Essen, H | 1 |
Vervoort-Peters, LH | 1 |
Struyker-Boudier, HA | 1 |
Smits, JF | 1 |
Itho, H | 1 |
Hirata, M | 1 |
Kawasaki, S | 1 |
Hayashi, J | 1 |
Oguro, M | 1 |
Otsuka, A | 1 |
Ogihara, T | 1 |
Mikami, H | 1 |
Kohara, K | 1 |
Katahira, K | 1 |
Tsunetoshi, T | 1 |
Kumahara, Y | 1 |
Arranz, CT | 1 |
Balaszczuk, AM | 1 |
Martínez-Seeber, A | 1 |
Gradin, K | 1 |
Elam, M | 1 |
Persson, B | 1 |
Nagahama, S | 1 |
Chen, YF | 1 |
Oparil, S | 1 |
Perry, HM | 1 |
Bruner, CA | 1 |
Neiko, EM | 1 |
Berezhnitskiĭ, MN | 1 |
Shvedenko, LA | 1 |
Kupnovitskaia, IG | 1 |
Mikhal'chuk, BD | 1 |
Sjövall, H | 1 |
Ely, D | 1 |
Westlander, G | 1 |
Köhlin, T | 1 |
Jodal, M | 1 |
Lundgren, O | 1 |
Zambraski, EJ | 1 |
Ciccone, CD | 1 |
Izzo, JL | 1 |
Kimura, Y | 1 |
Marzán, G | 1 |
Enero, MA | 1 |
Toal, CB | 1 |
Blair, ML | 1 |
Mangiapane, ML | 1 |
Wilczynski, EA | 2 |
Tucker, DC | 1 |
Domino, JV | 1 |
Kaskel, FJ | 1 |
Devarajan, P | 1 |
Persan, L | 1 |
Juno, CJ | 1 |
Wilson, TA | 1 |
McCaughran, JA | 1 |
2 reviews available for hexamethonium and Blood Pressure, High
Article | Year |
---|---|
Long-term blood pressure control: is there a set-point in the brain?
Topics: Animals; Arginine Vasopressin; Baroreflex; Blood Pressure; Brain; Heart Rate; Hexamethonium; Homeost | 2012 |
The evolution of antihypertensive therapy.
Topics: Antihypertensive Agents; Bis-Trimethylammonium Compounds; Blood Pressure; Calcium Channel Blockers; | 1985 |
273 other studies available for hexamethonium and Blood Pressure, High
Article | Year |
---|---|
Effects of Psidium guajava L. leaves extract on blood pressure control and IL-10 production in salt-dependent hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Chromatography, Liquid; Hexamethonium; Hypertensio | 2022 |
Concurrent exercise training induces additional benefits to hydrochlorothiazide: Evidence for an improvement of autonomic control and oxidative stress in a model of hypertension and postmenopause.
Topics: Animals; Baroreflex; Blood Pressure; Female; Heart Rate; Hexamethonium; Hydrochlorothiazide; Hyperte | 2023 |
Sub-chronic lead exposure produces β
Topics: Animals; Arterial Pressure; Cardiovascular Diseases; Down-Regulation; Heart Rate; Hexamethonium; Hyp | 2017 |
Chronic high-sodium diet intake after weaning lead to neurogenic hypertension in adult Wistar rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure Determination; Heart Rate; Hexamethonium; Hypertens | 2017 |
Intracranial pressure influences the level of sympathetic tone.
Topics: Animals; Baroreflex; Blood Pressure; Brain; Cerebrovascular Circulation; Hexamethonium; Hypertension | 2018 |
Wet lungs and a battered brain stem: can we stop one if we cannot stop the other?
Topics: Animals; Encephalitis, Viral; Enterovirus Infections; Hexamethonium; Hypertension; Male; Pulmonary E | 2013 |
Intravital Förster resonance energy transfer imaging reveals elevated [Ca2+]i and enhanced sympathetic tone in femoral arteries of angiotensin II-infused hypertensive biosensor mice.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biosensing Techniques; Calcium; Calcium Signaling; | 2013 |
CNS neuroplasticity and salt-sensitive hypertension induced by prior treatment with subpressor doses of ANG II or aldosterone.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Brain; Brain-Derived | 2014 |
High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Cyclic N-Oxides; Heart Rate; Hexamethonium; Hypertension; Male; Medulla Obl | 2008 |
Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension.
Topics: Acetophenones; Animals; Blood Pressure; Brain; Cyclic N-Oxides; Heart Rate; Hexamethonium; Hypertens | 2009 |
Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension.
Topics: Administration, Oral; Aldosterone; Animals; Blood Pressure; Body Weight; Brain; Disease Models, Anim | 2009 |
Antihypertensive effects of central ablations in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Baroreflex; Blood Pressur | 2009 |
Haemodynamic characteristics of hypertension induced by prenatal cortisol exposure in sheep.
Topics: Animals; Antihypertensive Agents; Female; Hemodynamics; Hexamethonium; Hydrocortisone; Hypertension; | 2009 |
Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide.
Topics: Angiotensin II; Animals; Blood Pressure; Blotting, Western; Disease Models, Animal; Enzyme Inhibitor | 2009 |
Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Drug Interactions; Electrop | 2011 |
Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs.
Topics: Acetanilides; Adrenergic Antagonists; Animals; Autonomic Agents; Coronary Circulation; Dogs; Dose-Re | 2011 |
Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Ganglionic Blockers; Heart Rate; Hexamethonium; Hypertensio | 2012 |
A role for nitric oxide within the nucleus tractus solitarii in the development of muscle mechanoreflex dysfunction in hypertension.
Topics: Animals; Blood Pressure; Disease Models, Animal; Enzyme Inhibitors; Ganglionic Blockers; Heart Rate; | 2012 |
Hexamethonium reverses the lethal cardiopulmonary damages in a rat model of brainstem lesions mimicking fatal enterovirus 71 encephalitis.
Topics: Animals; Biopsy, Needle; Brain Stem; Catecholamines; Diagnosis, Differential; Disease Models, Animal | 2013 |
Recovery of high blood pressure after chronic lesions of the commissural NTS in SHR.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Argini | 2003 |
Hexamethonium and glaucoma.
Topics: Glaucoma; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1952 |
Treatment of hypertension with orally and parenterally administered purified extracts of veratrum viride; comparison with ganglionic (Hexamethonium) and adrenergic blocking agents.
Topics: Adrenergic Antagonists; Ganglia; Hexamethonium; Hypertension; Veratrum; Veratrum Alkaloids | 1952 |
Hypotensive actions of hexamethonium bromide and some of its homologues; their use in high blood-pressure.
Topics: Autonomic Agents; Hexamethonium; Hypertension | 1952 |
The uses of hexamethonium.
Topics: Anesthesia; Cardiovascular Agents; Gastrointestinal Diseases; Hexamethonium; Humans; Hypertension; M | 1952 |
Treatment of hypertension with hexamethonium bromide.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1952 |
The management of hypertension with hexamethonium bromide.
Topics: Cardiovascular Agents; Disease Management; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1952 |
Hexamethonium and apresoline (1-hydrazinophthalazine).
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho | 1952 |
Hexamethonium ileus.
Topics: Hexamethonium; Hypertension; Ileus; Intestinal Obstruction; Muscle Relaxants, Central | 1953 |
The effects of hexamethonium on certain manifestations of congestive heart failure.
Topics: Cardiovascular Agents; Heart Failure; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
Continous oral hexamethonium in essential hypertension; further experiences in treatment.
Topics: Cardiovascular Agents; Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Centra | 1952 |
The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine.
Topics: Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics | 1953 |
[The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine].
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho | 1952 |
[Current medical and surgical therapy of permanent arterial hypertension; salt-free diet; tetraethylammonium; hexamethonium; extensive sympathectomies; arteriovenous fistula].
Topics: Arteriovenous Fistula; Diet, Sodium-Restricted; Fistula; Hexamethonium; Humans; Hypertension; Sympat | 1952 |
Results with oral hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the therapy of hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho | 1953 |
[Treatment of arterial hypertension with hexamethonium].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1952 |
Some reactions to apresoline, hexamethonium and hydergine.
Topics: Cardiovascular Agents; Ergoloid Mesylates; Ergot Alkaloids; Hexamethonium; Hydralazine; Hypertension | 1952 |
Sensitivity of autonomic ganglia to hexamethonium in hypertension.
Topics: Autonomic Agents; Ganglia, Autonomic; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
The treatment of hypertension with oral hexamethonium.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
Responses of the ballistocardiogram in hypertensive patients to the acute administration of apresoline, hexamethonium, veratrone, regitine and sodium amytal.
Topics: Amobarbital; Ballistocardiography; Barbiturates; Cardiovascular Agents; Hexamethonium; Hydralazine; | 1953 |
Dibenzyline: results of therapy in patients with hypertension and a comparison with hexamethonium, 1-hydrazinophthalazine and semipurified extracts of veratrum.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Phenoxyb | 1953 |
Parenteral hexamethonium in hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
Essential hypertension; treatment with hexamethonium and apresoline.
Topics: Cardiovascular Agents; Essential Hypertension; Hexamethonium; Hydralazine; Hypertension; Muscle Rela | 1953 |
Orally administered hexamethonium chloride in hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
A preliminary report on clinical experiences with hexamethonium and 1-hydrazinophthalazine in the treatment of diastolic hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Relaxants, Central; | 1953 |
Death associated with hexamethonium and 1-hydrazinophthalazine (apresoline) therapy.
Topics: Cardiovascular Agents; Death; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; S | 1953 |
The use of oral hexamethonium chloride (methium) in the treatment of hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
Clinical experiences with hexamethonium chloride in hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
The renal response to hexamethonium.
Topics: Hexamethonium; Hypertension; Kidney; Muscle Relaxants, Central | 1953 |
The acute effects of hexamethonium on renal hemodynamics in normotensive and hypertensive human subjects.
Topics: Blood Pressure; Hemodynamics; Hexamethonium; Humans; Hypertension; Kidney; Muscle Relaxants, Central | 1953 |
A critical evaluation of the hypotensive asction of hydrallazine, hexamethonium, tetraethylammonium and dibenzyline salts in human and experimental hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypotension; Muscle Relaxants, Cent | 1953 |
Further observations on the effects of autonomic blocking agents in patients with hypertension. I. General systemic effects of hexamethonium, pentamethonium, and hydrazinophthalazine.
Topics: Bis-Trimethylammonium Compounds; Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Mu | 1953 |
Clinical use of hydralazine and hexamethonium in treatment of hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho | 1953 |
Treatment of hypertension with hexamethonium alone and in combination with apresoline.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho | 1953 |
[Drug therapy of arterial hypertension; preliminary report on own experience with hexamethonium].
Topics: Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
Further observations on the effects of autonomic blocking agents in patients with hypertension. II. Hemodynamic, ballistocardiographic and electrocardiographic effects of hexamethonium and pentamethonium.
Topics: Bis-Trimethylammonium Compounds; Heart; Hemodynamics; Hexamethonium; Humans; Hypertension; Kidney; M | 1953 |
[The treatment of hypertension with hexamethonium and veriloid].
Topics: Hexamethonium; Hypertension; Muscle Relaxants, Central; Veratrum Alkaloids | 1953 |
The treatment of hypertension; experience of treatment with hexamethonium and veratrum viride preparation in 50 patients.
Topics: Hexamethonium; Hypertension; Muscle Relaxants, Central; Veratrum; Veratrum Alkaloids | 1953 |
Treatment of hypertension in elderly patients with methium chloride; preliminary report.
Topics: Aged; Cardiovascular Agents; Disease; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central | 1953 |
[Preliminary results in drug therapy of hypertension, with special reference to hexamethonium bromide].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
Effect of hexamethonium bromide on the cerebral circulation in hypertension.
Topics: Brain; Cerebrovascular Circulation; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
The treatment of hypertension with hexamethonium and hydrazinophthalazine (apresoline).
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho | 1953 |
Exercise tests during treatment of hypertension with hexamethonium.
Topics: Cardiovascular Agents; Exercise Test; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
Hexamethonium in polyvinylpyrrolidone.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Povidone | 1953 |
Newer drugs in hypertension; combined effects of 1-hydrazinophthalazine (apresoline) and hexamethonium salts; a preliminary report.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Salts; S | 1953 |
Preliminary observations of Rauwiloid-hexamethonium combined therapy of hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central; Rauwolfia; Se | 1953 |
Modification of the hypotensive action of 1-hydrazinophthalazine (apresoline) by priscoline, hexamethonium and section of the carotid sinus and aortic buffer nerves in normal and renal hypertensive dogs.
Topics: Animals; Aorta; Carotid Sinus; Dogs; Hexamethonium; Hydralazine; Hypertension; Kidney; Muscle Relaxa | 1953 |
Newer drugs in the treatment of hypertension. I. Use of hexamethonium salts.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts | 1953 |
Hexamethonium in the chronic treatment of hypertension; its effect on renal hemodynamics and on the excretion of water and electrolytes.
Topics: Electrolytes; Hemodynamics; Hexamethonium; Hypertension; Kidney; Muscle Relaxants, Central; Water | 1953 |
Hexamethonium and apresoline; their effects on ambulatory hypertensive patients.
Topics: Cardiovascular Agents; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Relaxants, Central; | 1953 |
Outpatient treatment of hypertension with hexamethonium and apresoline.
Topics: Ambulatory Care; Cardiovascular Agents; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Rel | 1953 |
Effect of hexamethonium on normotensive heart failure; a possible correlation between the mechanism of essential hypertension and normotensive heart failure.
Topics: Essential Hypertension; Heart Failure; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
Hexamethonium in the treatment of hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
[Results of treatment of arterial hypertension with hexamethonium and apresoline].
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho | 1953 |
[Hexamethonium in the treatment of hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
The effect of hexamethonium bromide upon coronary flow, cardiac work and cardiac efficiency in normotensive and renal hypertensive dogs.
Topics: Animals; Blood Pressure; Dogs; Heart; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
Practical details of the treatment of hypertension by hexamethonium salts and by pentamethylene 1:5-bis-N-(N-methylpyrrolidinium) bitartrate (M. & B. 2050A).
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts | 1953 |
[Vegolysen retard, a new hexamethonium preparation with prolonged effect].
Topics: Aged; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central; Povidone | 1953 |
Lung changes during hexamethonium therapy for hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Lung; Muscle Relaxants, Central | 1954 |
Hexamethonium and hydralazine hydrochloride for treatment of hypertension.
Topics: Cardiovascular Agents; Constipation; Hexamethonium; Hydralazine; Hypertension; Hypotension, Orthosta | 1954 |
[Behavior of hexamethonium in arterial hypertension of distinct etiopathogenesis: hexamethonium test and personal technic].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
The haemodynamic effects of hexamethonium bromide in patients with pulmonary hypertension and heart failure.
Topics: Blood Circulation; Heart Failure; Hemodynamics; Hexamethonium; Hypertension; Hypertension, Pulmonary | 1953 |
Muscular exercise in essential hypertension; the effect of hexamethonium chloride (C6).
Topics: Essential Hypertension; Exercise; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central; Mu | 1953 |
The treatment of the ambulatory hypertensive patient with hexamethonium administered orally.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
Use of hexamethonium in arterial hypertension.
Topics: Antihypertensive Agents; Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Centr | 1954 |
Intravenous hexamethonium sensitivity and responses to oral treatment.
Topics: Administration, Oral; Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
The effect of prolonged sodium depletion and of hydralazine hydrochloride and hexamethonium bromide on the digital vascular resistance in primary hypertension.
Topics: Essential Hypertension; Fingers; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central | 1954 |
[Use of hexamethonium salts in hypertensive disease].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts | 1954 |
[Essential hypertension. II. Acute changes of renal function caused by hexamethonium bitartrate].
Topics: Essential Hypertension; Hexamethonium; Hypertension; Kidney; Muscle Relaxants, Central | 1954 |
[Relations between arterial circulation and renal function following administration of hexamethonium bromide].
Topics: Arteries; Blood Circulation; Hexamethonium; Hypertension; Kidney; Muscle Relaxants, Central; Pharmac | 1954 |
[Essay of the treatment of essential arterial hypertension with oral hexamethonium chloride].
Topics: Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
The mechanism of arterial hypertension: a comparison of the effects of hexamethonium bromide in hypertensive and normotensive persons.
Topics: Blood Pressure; Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Centra | 1954 |
Changes in peripheral circulation and body temperature after hexamethonium bromide.
Topics: Blood Circulation; Body Temperature; Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Rela | 1954 |
Bleeding peptic ulcer complicating hydralazine and hexamethonium bromide therapy.
Topics: Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Peptic Ulcer; Peptic Ulcer Hemo | 1954 |
[Action of oral hexamethonium chloride in the treatment of arterial hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central | 1954 |
[Hexamethonium in the treatment of arterial hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
[Effect of hexamethonium on photoplethysmographic tracings in hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1953 |
[Hexamethonium in therapy of acute hypertensive crises, as illustrated by case reports].
Topics: Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
[Practice and results of the use of hexamethonium in the treatment of arterial hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
Appraisal of methium chloride with Rauwolfia in ambulatory hypertensive patients.
Topics: Hexamethonium; Hypertension; Hypnotics and Sedatives; Muscle Relaxants, Central; Rauwolfia | 1954 |
[Hexamethonium, apresoline and pyretotherapy in the treatment of arterial hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hyperthermia, Induced; Muscle Relax | 1954 |
[Observations on the treatment of arterial hypertension with hexamethonium with hydergine].
Topics: Cardiovascular Agents; Ergoloid Mesylates; Ergot Alkaloids; Hexamethonium; Hypertension; Muscle Rela | 1954 |
[Hexamethonium in therapy of arterial hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
Outpatient treatment of hypertension with hexamethonium and hydralazine; a preliminary report.
Topics: Ambulatory Care; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Relaxants, Central; Outpat | 1954 |
Hexamethonium treatment of arterial hypertension.
Topics: Hexamethonium; Humans; Hypertension; Osteomyelitis | 1954 |
Cerebral hemodynamic studies on hypertensive-atherosclerotic subjects during hexamethonium therapy.
Topics: Arteriosclerosis; Brain; Cardiovascular System; Hemodynamics; Hexamethonium; Hypertension; Muscle Re | 1954 |
[Hexamethonium bromide test in hypertensive endocrine diseases].
Topics: Cardiovascular Agents; Endocrine System Diseases; Hexamethonium; Hypertension; Muscle Relaxants, Cen | 1954 |
Treatment of hypertension; long-term results with alseroxylon (rauwiloid) alone and combined with hexamethonium administered orally.
Topics: Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Hypnotics and Sedatives; Muscle Relaxant | 1954 |
Comparison of effects on hypertension of hexamethonium and pentapyrrolidinium injected subcutaneously.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
A comparison of the effects of hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the treatment of hypertension.
Topics: Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics | 1953 |
Blood pressure reduction in arterial hypertension by hexamethonium and pentapyrrolidinium salts.
Topics: Blood Pressure; Cardiovascular Agents; Hexamethonium; Hypertension; Hypotension; Muscle Relaxants, C | 1954 |
Hypertension and its control by hexamethonium.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
Hexamethonium contributing to fatal shock in hypertensive epistaxis.
Topics: Cardiovascular Agents; Epistaxis; Hexamethonium; Hypertension; Muscle Relaxants, Central; Shock | 1954 |
[Clinical study of hexamethonium in arterial hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central | 1954 |
Hexamethonium and apresoline (L-hydrazinophthalazine) in the treatment of malignant hypertension; report of a case.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypertension, Malignant; Muscle Rel | 1954 |
[Administration of hexamethonium to patients with severe hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1954 |
Treatment of hypertension with oral reserpine alone and in combination with hydralazine or hexamethonium.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypnotics and Sedatives; Muscle Rel | 1955 |
The effect of hexamethonium upon cerebral blood flow and metabolism in patients with premalignant and malignant hypertension.
Topics: Brain; Cerebrovascular Circulation; Hexamethonium; Humans; Hypertension; Hypertension, Malignant; Mu | 1955 |
The effects of intravenous hexamethonium on venous pressure of normotensive and hypertensive patients with and without congestive heart failure.
Topics: Blood Pressure; Blood Pressure Determination; Heart Failure; Hexamethonium; Humans; Hypertension; Ve | 1955 |
[Effect of hexamethonium loading test on ballistocardiogram and ECG in hypertensive subjects].
Topics: Ballistocardiography; Cardiovascular Agents; Electrocardiography; Hexamethonium; Humans; Hypertensio | 1954 |
Severe hypertension treated with hexamethonium bromide in retard medium.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1955 |
[New trends in the treatment of hypertension. II. Experimental investigations on two new Hungarian preparations; hexamethonium, N. 310].
Topics: Autonomic Agents; Autonomic Nervous System; Hexamethonium; Humans; Hypertension; Muscle Relaxants, C | 1955 |
Permanent bilateral blindness following the use of hexamethonium chloride.
Topics: Blindness; Hexamethonium; Hypertension; Muscle Relaxants, Central; Vision Disorders | 1955 |
Newer drugs in the treatment of hypertension. II. Use of hexamethonium in combination with hydralazine.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho | 1955 |
[Vectorcardiographic studies in hypertensive patients with massive blood pressure reduction by hexamethonium; contribution to the theory of ventricular gradients].
Topics: Blood Pressure; Hexamethonium; Humans; Hypertension; Hypotension; Muscle Relaxants, Central; Vectorc | 1955 |
Hematuria during treatment of severe hypertension with hexamethonium bromide and pentolinium tartrate.
Topics: Cardiovascular Agents; Hematuria; Hexamethonium; Hypertension; Muscle Relaxants, Central; Pentoliniu | 1955 |
Pentolinium and hexamethonium combined with Rauwolfia in the treatment of hypertension.
Topics: Antihypertensive Agents; Cardiovascular Agents; Hexamethonium; Hypertension; Hypnotics and Sedatives | 1955 |
Methium chloride with reserpine, a new antihypertensive combination.
Topics: Antihypertensive Agents; Cardiovascular Agents; Chlorides; Hexamethonium; Hypertension; Muscle Relax | 1955 |
The effect of pentolinium on renal hemodynamics and water and electrolyte excretion: a comparison with hexamethonium.
Topics: Electrolytes; Hemodynamics; Hexamethonium; Hypertension; Kidney; Muscle Relaxants, Central; Pentolin | 1956 |
[The treatment of hypertension with hexamethonium bromide and Rauwolfia preparations].
Topics: Antihypertensive Agents; Hexamethonium; Hypertension; Hypnotics and Sedatives; Muscle Relaxants, Cen | 1955 |
[The hexamethonium in hypertensive encephalopathy].
Topics: Hexamethonium; Hypertension; Hypertensive Encephalopathy; Muscle Relaxants, Central; Vascular Diseas | 1955 |
[Studies of the effect of small doses of hexamethonium on blood circulation in normal and hypertensive subjects].
Topics: Blood Circulation; Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Cen | 1956 |
Clinical observations on the oral use of hexamethonium, hydralazine, and rauwolfia extracts in essential hypertension.
Topics: Antihypertensive Agents; Essential Hypertension; Hexamethonium; Humans; Hydralazine; Hypertension; M | 1956 |
The effect of a ganglionic blocking agent (hexamethonium) on renal function and on excretion of water and electrolytes in hypertension and in congestive heart failure.
Topics: Electrolytes; Ganglionic Blockers; Heart Failure; Hexamethonium; Humans; Hypertension; Kidney Functi | 1956 |
[Prolonged treatment of essential hypertension with hexamethonium and serpasil].
Topics: Antihypertensive Agents; Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Cent | 1956 |
Renal haemodynamic effects of hypotensive drugs. I. Acute effects of hexamethonium bromide before and after treatment with reserpine.
Topics: Antihypertensive Agents; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; | 1957 |
Renal haemodynamic effects of hypotensive drugs. I. Acute effects of hexamethonium bromide before and after treatment with reserpine.
Topics: Antihypertensive Agents; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; | 1957 |
Renal haemodynamic effects of hypotensive drugs. I. Acute effects of hexamethonium bromide before and after treatment with reserpine.
Topics: Antihypertensive Agents; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; | 1957 |
Renal haemodynamic effects of hypotensive drugs. I. Acute effects of hexamethonium bromide before and after treatment with reserpine.
Topics: Antihypertensive Agents; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; | 1957 |
[Rauwolfia serpentina extracts combined with hexamethonium in therapy of arterial hypertension in diabetics].
Topics: Diabetes Complications; Diabetes Mellitus; Hexamethonium; Hexamethonium Compounds; Humans; Hypertens | 1957 |
Gastrointestinal roentgen findings due to untoward effects of hexamethonium.
Topics: Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Intestinal Obstruction; Stomach; Stoma | 1957 |
The effect of hexamethonium upon the pulmonary vascular resistance in mitral stenosis.
Topics: Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Mitral Valve Stenosis; Vascular Diseas | 1957 |
Hexamethonium chloride with reserpine in the treatment of severe essential hypertension.
Topics: Essential Hypertension; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Reserpine | 1958 |
Vascular reactivity in experimental hypertension measured after hexamethonium.
Topics: Blood Vessels; Hexamethonium; Hypertension; Nitrites; Norepinephrine | 1958 |
Pneumonitis as a complication of hexamethonium therapy.
Topics: Glomerulonephritis; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Pneumonia; Vascula | 1958 |
[Experiences with hexamethonium salts in rectal administration in hypertension].
Topics: Administration, Rectal; Hexamethonium; Hexamethonium Compounds; Hypertension; Salts | 1958 |
[Date on the action of hexamethonium in arterial hypertension].
Topics: Hexamethonium; Hexamethonium Compounds; Hypertension; Phoeniceae | 1958 |
Pulmonary changes associated with hexamethonium therapy.
Topics: Hexamethonium; Hexamethonium Compounds; Hypertension; Pneumonia | 1959 |
Pressor effect of subcutaneous renin in dogs, and effect of reserpine, 1-hydrazinophthalazine and hexamethonium on renin hypertension.
Topics: Animals; Dogs; Endopeptidases; Hexamethonium; Hexamethonium Compounds; Hydralazine; Hydrolases; Hype | 1959 |
[Result of treatment of arterial hypertension with hexamethonium, thalazine & other drugs].
Topics: Hexamethonium; Hexamethonium Compounds; Humans; Hydralazine; Hypertension; Hypertension, Portal | 1959 |
[Dynamics of serum protein fractions during the treatment of hypertension with Rauwolfia serpentina preparations and hexonium].
Topics: Bis-Trimethylammonium Compounds; Blood Proteins; Hexamethonium; Hypertension; Rauwolfia; Serum Album | 1961 |
Hexamethonium trial as a diagnostic test of the principal forms of arterial hypertension
Topics: Diagnostic Tests, Routine; Hexamethonium; Hexamethonium Compounds; Hypertension | 1960 |
[Treatment of patients with hypertension with hexonium and reserpine].
Topics: Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Reserpine | 1962 |
[The treatment of hypertension by Depressin].
Topics: Antihypertensive Agents; Hexamethonium; Humans; Hypertension; Imidazoles; Pentobarbital; Reserpine | 1962 |
[Effect of Gangleron and Hexonium on regional blood circulation in patients with hypertension].
Topics: Ganglionic Blockers; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Plethysmography | 1962 |
[DIFFERENTIATION BY HEXAMETHONIUM OF THE HYPERTENSIVE ACTIONS RESPECTIVELY EXERCISED BY POTASSIUM ION AND ACETYLCHOLINE].
Topics: Acetylcholine; Animals; Blood Pressure; Blood Pressure Determination; Dogs; Exercise; Hexamethonium; | 1964 |
[ON DEPRESSIN THERAPY OF PATIENTS WITH RESERPINE-RESISTANT FORMS OF HYPERTENSION].
Topics: Antihypertensive Agents; Hexamethonium; Humans; Hypertension; Reserpine | 1964 |
[USE OF HEXONIUM IN A POLYCLINIC].
Topics: Drug Therapy; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Reserpine | 1965 |
Acute hemodynamic effects of hexamethonium (C6) in patients with emphysematous pulmonary hypertension.
Topics: Emphysema; Hemodynamics; Hexamethonium; Humans; Hypertension; Hypertension, Pulmonary; Muscle Relaxa | 1955 |
Pulmonary complications during treatment with hexamethonium.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Lung; Muscle Relaxants, Central | 1955 |
Hexamethonium, hydralazine and rauwolfia serpentina therapy in hypertension.
Topics: Antihypertensive Agents; Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Rel | 1955 |
[Combination of hexamethonium and hydrazinophthalazine in the treatment of arterial hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho | 1954 |
[Treatment of essential arterial hypertension with hexamethonium chloride].
Topics: Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1955 |
Oral hexamethonium in hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1955 |
Cardiovascular and renal responses to the combination of hexamethonium and 1-hydrazinophthalazine (apresoline) in hypertensive subjects.
Topics: Cardiovascular System; Hexamethonium; Hydralazine; Hypertension; Kidney; Muscle Relaxants, Central; | 1955 |
[Prolonged-action hexamethonium in therapy of arterial hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1955 |
Evaluation of drug therapy of hypertension; experience with ansolysen, hexamethonium, apresoline, and reserpine.
Topics: Drug Therapy; Hexamethonium; Hydralazine; Hypertension; Pentolinium Tartrate; Reserpine | 1955 |
Hypertension treatment with alkaloids of Veratrum viride and Veratrum album alone or in combination with hexamethonium salts.
Topics: Alkaloids; Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts; Ver | 1955 |
[Effect of hexamethonium on renal circulation and function in cardiacs and hypertensives].
Topics: Heart Diseases; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Kidney; Renal Circulat | 1959 |
Observations on the responses of rats with spontaneous hypertension and control rats to pressor drugs and to hexamethonium.
Topics: Arginine Vasopressin; Disease; Epinephrine; Hexamethonium; Hypertension; Rats; Rodent Diseases; Thio | 1962 |
Blood pressure effects of intravenous apomorphine in conscious deoxycorticosterone-acetate salt-hypertensive rats.
Topics: Animals; Apomorphine; Behavior, Animal; Blood Pressure; Desoxycorticosterone; Domperidone; Dopamine | 2003 |
Treatment of severe hypertension with hexamethonium bromide.
Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Hexamethonium; Hypert | 1950 |
Some results of treatment with hexamethonium bromide in cases of vascular hypertension.
Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Hexamethonium; Hypert | 1951 |
Hexamethonium bromide in vascular hypertension.
Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Hexamethonium; Hypert | 1951 |
Treatment of arterial hypertension by penta- and hexamethonium salts; based on 150 tests on hypertensives of varied aetiology and 53 patients treated for periods of two to fourteen months.
Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Hexamethonium; Hypert | 1951 |
Veratrum viride and hexamethonium in the treatment of severe diastolic hypertension.
Topics: Autonomic Nervous System Diseases; Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure D | 1951 |
Oral hexamethonium bromide in essential hypertension.
Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Essential Hypertensio | 1951 |
Syncope during hexamethonium administration.
Topics: Animals; Anura; Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Hexam | 1951 |
Effect of hexamethonium bromide in arterial hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1951 |
Treatment of hypertension with hexamethonium bromide.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1951 |
[Hexamethonium therapy of essential hypertension].
Topics: Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1951 |
M. & B. 1863, a homologue of hexamethonium, in treatment of hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1952 |
The treatment of hypertension with hexamethonium.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1952 |
[Hexamethonium bromide in hypertension therapy].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1951 |
Control of hypertension by hexamethonium and 1-hydrazinophthalazine; preliminary observations.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central | 1952 |
Comparison of the effects of veratrum alkaloids and of hexamethonium bromide upon the blood pressure in arterial hypertension.
Topics: Blood Pressure; Blood Pressure Determination; Cardiovascular Agents; Hexamethonium; Humans; Hyperten | 1952 |
Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central | 1952 |
Some observations on the use of hexamethonium bromide in the treatment of ambulant hypertensives.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1952 |
Treatment of hypertension; results with hexamethonium salts administered orally.
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts | 1952 |
[Hexamethonium salts in hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts | 1952 |
[Action on hexamethonium bromide on arterial hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1952 |
NEW approved drugs: hexamethonium bromide; hydralazine hydrochloride.
Topics: Drug Approval; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central | 1952 |
[Hexamethonium therapy of arterial hypertension].
Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central | 1952 |
[Penta- and hexamethonium in arterial hypertension].
Topics: Hexamethonium; Hypertension; Muscle Relaxants, Central; Oligosaccharides; Rubiaceae | 1952 |
Pentamethonium and hexamethonium iodide in investigation of peripheral vascular disease and hypertension.
Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Blood Vessels; Hexame | 1950 |
The treatment of high blood pressure with hexamethonium iodide.
Topics: Blood Pressure; Blood Pressure Determination; Hexamethonium; Hypertension; Iodine; Iodine Isotopes | 1950 |
Contribution of the subfornical organ to angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Drinking; Heart Rate; Hexamethoniu | 2005 |
Sex differences in the development of angiotensin II-induced hypertension in conscious mice.
Topics: Angiotensin II; Animals; Baroreflex; Blood Pressure; Consciousness; Female; Ganglionic Blockers; Hea | 2005 |
Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Desoxycorticosterone; Drinking; Eating; Enzyme Inhibi | 2006 |
Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Brain; Car | 2006 |
Exercise pressor reflex function is altered in spontaneously hypertensive rats.
Topics: Animals; Arteries; Baroreflex; Blood Pressure; Echocardiography; Electric Stimulation; Ganglionic Bl | 2006 |
Increased sympathetic activity in rats submitted to chronic intermittent hypoxia.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Chronic Disease; Disease Models, A | 2007 |
Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Blood Pressure; Body Weight; Captop | 2007 |
Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arginine Vasopressin; Baroreflex; Blood Glucose; B | 2007 |
Acute antihypertensive action of Tempol in the spontaneously hypertensive rat.
Topics: Amitrole; Animals; Antihypertensive Agents; Blood Pressure; Buthionine Sulfoximine; Catalase; Cromak | 2007 |
Effect of peripheral sympathetic nerve dysfunction on salt sensitivity of arterial pressure.
Topics: Animals; Antihypertensive Agents; Autonomic Nervous System Diseases; Blood Pressure; Dose-Response R | 2008 |
Hyperinsulinemic rats are normotensive but sensitized to angiotensin II.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Ag | 2008 |
Post-resistance exercise hypotension in spontaneously hypertensive rats is mediated by nitric oxide.
Topics: Animals; Blood Pressure; Hexamethonium; Hypertension; Hypotension; Male; NG-Nitroarginine Methyl Est | 2008 |
Preload and afterload reduction in treating congestive heart failure.
Topics: Autonomic Nerve Block; Heart Failure; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Humans; | 1984 |
Factors influencing the altered pain perception in the spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Heart Rate; Hexamethonium; Hexamethonium Compounds; Hypertension; Male; Mus | 1982 |
GABA receptor binding and hemodynamic responses to ICV GABA in adult spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain; gamma-Aminobutyric Acid; Heart Rate; Hemody | 1983 |
[Combined treatment of hypertension patients].
Topics: Adolescent; Adult; Antihypertensive Agents; Clonidine; Drug Combinations; Drug Evaluation; Drug Ther | 1984 |
Contribution of vasopressin to hypertension after solitary tract lesioning in the dog.
Topics: Acute Disease; Animals; Arginine Vasopressin; Blood Pressure; Dogs; Heart Rate; Hexamethonium; Hexam | 1984 |
Effect of methylguanidine on rat blood pressure: role of endothelial nitric oxide synthase.
Topics: Animals; Arginine; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Endothe | 1995 |
Contribution of alpha- and beta- adrenoceptors and neuropeptide-Y to autonomic dysreflexia.
Topics: Animals; Autonomic Nervous System Diseases; Blood Pressure; Ganglionic Blockers; Heart Rate; Hexamet | 1995 |
Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Dogs; Female; Heart Rate; Hexamethoni | 1993 |
Antihypertensive effect of taurine on salt-induced hypertension.
Topics: Animals; Blood Pressure; Brain; Hexamethonium; Hypertension; Hypothalamus; Injections, Intraventricu | 1994 |
Arterial hypertrophy and pressor responsiveness during development of hypertension in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Ganglionic Blockers; Heart Ventricles; Hemodynamics; Hexamethonium; Hexamet | 1994 |
Involvement of the sympathetic nervous system in antihypertensive effect of cicletanine in salt-loaded young spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dopamine; Hexamethonium; Hypertension; Male; Norep | 1994 |
Excitatory amino acid receptors in the rostral ventrolateral medulla mediate hypertension induced by carotid body chemoreceptor stimulation.
Topics: Animals; Blood Pressure; Carotid Body; Cordotomy; Excitatory Amino Acid Antagonists; Heart Rate; Hex | 1994 |
Study of the hemodynamic contributing factors of spontaneously hypertensive rats in the early stage of established hypertension.
Topics: Animals; Blood Pressure; Cardiac Output; Cerebrovascular Disorders; Hemodynamics; Hexamethonium; Hex | 1993 |
Contribution of the sympathetic nervous system to salt-sensitivity in lifetime captopril-treated spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Clonidine; Hexamethonium; Hypertension; | 1995 |
Parasympathetic component of 5-hydroxytryptamine-induced pulmonary dysfunctions in healthy calves.
Topics: Aging; Animals; Apnea; Atropine; Bradycardia; Cattle; Cattle Diseases; Cholinergic Agents; Ganglioni | 1996 |
Central GABAergic mechanisms are defective in salt-induced hypertension in borderline hypertensive rats.
Topics: Animals; Antihypertensive Agents; Bicuculline; Blood Pressure; Consciousness; GABA Antagonists; gamm | 1995 |
Contribution of the sympathetic nervous system to hypertensive response to insulin excess in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Clonidine; Ganglion | 1996 |
Tachyphylaxis and sensitization to nicotine-induced tachycardiac and pressor effects after nicotine infusions.
Topics: Animals; Blood Pressure; Bradycardia; Decerebrate State; Drug Administration Schedule; Ganglionic Bl | 1997 |
Autonomic control of ultradian and circadian rhythms of blood pressure, heart rate, and baroreflex sensitivity in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Autonomic Nervous System; Blood Pressure; Circadian Rhythm; H | 1997 |
Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Catecholamines; Dietary | 1997 |
Sympathetic nervous system and hypertension during prolonged TxA2/PGH2 receptor activation in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Antihypertensive Agents | 1997 |
Food restriction attenuates the blood pressure response to paraventricular hypothalamic nuclei lesions in aortic coarctation hypertension.
Topics: Adrenergic alpha-Agonists; Animals; Aortic Coarctation; Atropine; Blood Glucose; Blood Pressure; Bod | 1998 |
Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive rat versus Wistar-Kyoto rat.
Topics: Angiotensin II; Animals; Blood Pressure; Catecholamines; Ganglionic Blockers; Heart Rate; Heart Vent | 1998 |
Nitric oxide dependent vasodilation in young spontaneously hypertensive rats.
Topics: Aging; Animals; Antihypertensive Agents; Blood Pressure; Drug Interactions; Enzyme Inhibitors; Hexam | 1998 |
Attenuation of cardiac but not vascular component in baroreflex of spontaneously hypertensive rats.
Topics: Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Atropine; Baroreflex; Blood Pressure; B | 1998 |
The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes.
Topics: Angiotensins; Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Brain Chemistr | 1998 |
Daily exercise enhances acetylcholine-induced dilation in mesenteric and hindlimb vasculature of hypertensive rats.
Topics: Acetylcholine; Animals; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Follow-Up Studies; | 1999 |
Role of cholinergic receptors in adrenal catecholamine secretion in spontaneously hypertensive rats.
Topics: Adrenal Glands; Animals; Atropine; Electric Stimulation; Epinephrine; Hexamethonium; Hypertension; I | 1999 |
The pharmacological effects of an aqueous extract from Acacia nilotica seeds.
Topics: Acacia; Acetylcholine; Animals; Atropine; Blood Pressure; Cats; Dose-Response Relationship, Drug; Gu | 1999 |
Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Glucose; B | 2000 |
Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension.
Topics: Animals; Atrasentan; Blood Volume; Consciousness; Desoxycorticosterone; Endothelin Receptor Antagoni | 2000 |
Right ventricular pressure and dilation during pressure overload determine dysfunction after pressure overload.
Topics: Animals; Atropine; Cardiac Catheterization; Cardiotonic Agents; Cardiovascular Agents; Diastole; Dil | 2000 |
Pathophysiological role of leptin in obesity-related hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; alpha-MSH; Animals; Blood Pressure; Body | 2000 |
Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition.
Topics: Angiotensin Receptor Antagonists; Angiotensins; Animals; Antihypertensive Agents; Benzimidazoles; Bi | 2000 |
Inhibition of abnormal hindquarter vascular tone in spontaneously hypertensive rats with chlorpromazine.
Topics: Animals; Chlorpromazine; Drug Administration Schedule; Female; Ganglionic Blockers; Hexamethonium; H | 2000 |
Control of renin secretion from adrenal gland in transgenic Ren-2 and normal rats.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitor | 2001 |
Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Hemody | 2001 |
Contribution of central amiloride-sensitive transport systems to the development of hypertension in spontaneously hypertensive rats.
Topics: Amiloride; Angiotensin II; Animals; Blood Pressure; Body Weight; Brain; Carrier Proteins; Diuretics; | 2001 |
Is clinical research still too haphazard.
Topics: Antihypertensive Agents; Biomedical Research; Clinical Trials as Topic; Hexamethonium; Humans; Hyper | 2001 |
Contribution of endogenous vasopressin to regional hemodynamics in borderline-hypertensive Hiroshima rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Argini | 2002 |
Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Attention Deficit Disorder with Hyperactivity; Beh | 2002 |
History of research into hypertension.
Topics: Bretylium Compounds; Ganglionic Blockers; Hexamethonium; Hexamethonium Compounds; History, 20th Cent | 1992 |
Role of the sympathetic nervous system in the alcohol-guanabenz hemodynamic interaction.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Catecholamines; Dose-Response Relationship, Drug; | 1992 |
Blockade of acute hypertensive response does not prevent changes in behavior or in CSF acetylcholine (ACH) content following traumatic brain injury (TBI).
Topics: Acetylcholine; Analysis of Variance; Animals; Axonal Transport; Behavior, Animal; Blood Pressure; Br | 1992 |
Hexamethonium and midazolam terminate dysrhythmias and hypertension caused by intracerebroventricular bupivacaine in rabbits.
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Brain; Bupivacaine; Halotha | 1991 |
Lateral parabrachial nucleus and angiotensin II-induced hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Blood Pressure; Gan | 1991 |
Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area.
Topics: Animals; Blood Pressure; Cats; Cyproheptadine; Female; Heart Rate; Hexamethonium; Hexamethonium Comp | 1991 |
Autoregulatory capacity in renal and mesenteric vasculatures of mineralocorticoid hypertensive dogs.
Topics: Adenosine; Animals; Blood Pressure; Desoxycorticosterone; Dogs; Female; Ganglionic Blockers; Hexamet | 1991 |
Suppression of the renin-angiotensin system induced by streptozotocin treatment in neonatal spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Diabetes Mellitus, Experim | 1990 |
Further evidence for abnormal hindquarter tone in spontaneously hypertensive rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Ganglia, Sympathetic; Ganglionic Blockers; Hexamethon | 1990 |
Role of afferent renal nerves in spontaneous hypertension in rats.
Topics: Afferent Pathways; Animals; Female; Ganglia, Spinal; Ganglionectomy; Hexamethonium; Hexamethonium Co | 1989 |
Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Desoxycorticosterone; Epinephrine; Hexamethonium; Hex | 1989 |
Contribution of the baroreflex afferent nerves to the production of vasoconstricted hypertension in volume-expanded dogs.
Topics: Afferent Pathways; Animals; Blood Pressure; Blood Volume; Diuresis; Dogs; Hemodynamics; Hexamethoniu | 1989 |
Role of autonomic nervous system on heart rate in experimental hypertension.
Topics: Animals; Atropine; Autonomic Nervous System; Heart Conduction System; Heart Rate; Hemicholinium 3; H | 1985 |
Chronic salt loading and central adrenergic mechanisms in the spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Central Nervous System; Clonidine; Dopamine; Heart Rate; Hexamethonium; Hex | 1985 |
Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
Topics: Adrenal Medulla; Animals; Blood Pressure; Bromocriptine; Depression, Chemical; Desoxycorticosterone; | 1985 |
Neurohumoral contributions to chronic angiotensin-induced hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Blood Pressure; Blo | 1986 |
[Effect of depression and dopegit on regional blood flow in patients with hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Blood Circulation; Female; Hexamethonium; Hexamethonium Compou | 1986 |
The adrenergic nervous control of fluid transport in the small intestine of normotensive and spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic Fibers; Animals; Blood Pressure; Electric Stimulation; Hexa | 1986 |
The role of the sympathetic nervous system in 2-kidney DOCA-hypertensive Yucatan miniature swine.
Topics: Animals; Blood Pressure; Cardiac Output; Catecholamines; Desoxycorticosterone; Female; Heart Rate; H | 1986 |
Brain renin angiotensin system contributes to the salt-induced enhancement of hypertension in SHR.
Topics: Angiotensin II; Animals; Blood Pressure; Brain; Captopril; Dose-Response Relationship, Drug; Hexamet | 1986 |
Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
Topics: Animals; Blood Pressure; Cold Temperature; Desoxycorticosterone; Hexamethonium; Hexamethonium Compou | 1987 |
[Changes in the sensitivity of cardiovascular beta adrenergic receptors after sinoaortic denervation in rats].
Topics: Animals; Blood Pressure; Denervation; Female; Hexamethonium; Hexamethonium Compounds; Hypertension; | 1986 |
Dietary sodium restriction, blood pressure and sympathetic activity in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Epinephrine; Ganglia, Sympathetic; He | 1987 |
The area postrema in deoxycorticosterone-salt hypertension in rats.
Topics: Animals; Blood Pressure; Body Water; Cerebral Ventricles; Desoxycorticosterone; Ganglionic Blockers; | 1987 |
Prevention of hypertension and maintenance of normotension in spontaneously hypertensive rats is dependent on continuous severe dietary sodium restriction.
Topics: Aging; Animals; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Eating; Hexamethonium; Hexamet | 1987 |
Dietary sodium intake and age in spontaneously hypertensive rats: effects on blood pressure and sympathetic activity.
Topics: Aging; Animals; Blood Pressure; Body Weight; Catecholamines; Diet, Sodium-Restricted; Growth Disorde | 1987 |
Balance among autonomic controls of heart rate in neonatal spontaneously hypertensive and borderline hypertensive rats.
Topics: Age Factors; Animals; Animals, Newborn; Antihypertensive Agents; Atenolol; Atropine Derivatives; Aut | 1988 |
Ontogeny of blood pressure in the inbred Dahl hypertension-sensitive and -resistant rat.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Hexamethonium; Hexamethonium Compounds; Hypertension; | 1988 |